Cancer Stem Cells (CSCs) Markers (EpCAM CD133 CD44)

Cancer Stem Cells (CSCs) are a small subpopulation of cells within tumors with capabilities of self-renewal, differentiation, and tumorigenicity when transplanted into an animal host. A number of cell surface markers such as CD44, CD24, and CD133 are often used to identify and enrich CSCs.

Exosome Biomarker in Pathological ( CD9, CD63, ALIX )

Caspases in Apoptosis ( Caspase-3, Caspase-8, Caspase-9 )

CD133 cancer stem cell marker (IR30-78 IR30-79)

ER stress sensors ( CHOP, PERK, ATF6, IRE1 ) IR132-533 IR129-522 IR127-515 IR133-535 IR135-538

Neuroscience Markers Antibodies

EMT Marker Antibody Panel

EMT antibody panel (IR5001)
*Benefits
- Includes both epithelial and mesenchymal markers
- Includes the most suitable loading control

Real-IHC Ab Breast Cancer Biomarker

Liquid Biopsy / CTC detection antibody

CTC , Circulating Tumor Cells
Detection Antibody

EpCAM CTC capturing antibody (Biotin label)
PanCK CTC detecting antibody (FITC label)
CD45 CTC detecting antibody (PE label)

CD45 / pan-CK antibody for CTC / CTM

Research to Cancer Biomarker

Epithelial IHC Antibody

ER PR HER2 breast cancer biomarker

Angiogenesis Dual Antibody

Ki-67

Ultraspecific E-cadherin / N-cadherin Antibody

Topic Target in Tumor Progression and Metastasis

Epithelial Cell Marker

ER stress Induced Autophagy

CD44 multifunctional in regulates Cancer

Role of TGF beta in Cancer

IReal Antibody List

IReal Antibody

EMT marker Panel

Change of antibody signal in accordance with defined biological characteristics of target protein following specific sample. Also, analysis of signals from various cell

MMP Remodeling Antibody Panel

MMP Remodeling antibody panel (IR5002)
*Benefits
-Drug treatment and conditional medium for MMP Biological

Cell Cycle Regulation

CD44 multifunctional in regulates Cancer

Cytokeratins  as  Cancer Biomarkers